Elsevier

Sleep Medicine

Volume 39, November 2017, Pages 95-100
Sleep Medicine

Original Article
Comorbidity of narcolepsy and depressive disorders: a nationwide population-based study in Taiwan

https://doi.org/10.1016/j.sleep.2017.07.022Get rights and content

Highlights

  • The relationship between narcolepsy and depressive disorders was investigated.

  • Patients with narcolepsy had more than a six-fold greater risk of comorbidity with depression than controls.

  • More than 50% had been diagnosed with depression prior to narcolepsy.

  • Clinicians must pay attention to the comorbidity of narcolepsy and depression.

Abstract

Objective

Narcolepsy is a chronic sleep disorder that is likely to have neuropsychiatric comorbidities. Depression is a serious mood disorder that affects individuals' daily activities and functions. The current study aimed to investigate the relationship between narcolepsy and depressive disorders.

Methods

The study consisted of patients diagnosed with narcolepsy between January 2002, and December 2011 (n = 258), and age-matched and gender-matched controls (n = 2580) from Taiwan's National Health Insurance database. Both the patients and the controls were monitored through December 31, 2011, to identify the occurrence of a depressive disorder. A multivariate logistic regression model was used to assess the narcolepsy's potential influence on the comorbidity of a depressive disorder.

Results

During the study period, 32.7%, 24.8%, and 10.9% of the narcoleptic patients were comorbid with any depressive disorder, dysthymic disorder, and major depressive disorder, respectively. When compared to the control subjects, the patients with narcolepsy were at greater risks of having any depressive disorder (aOR 6.77; 95% CI 4.90–9.37), dysthymic disorder (aOR 6.62; 95% CI 4.61–9.57), and major depressive disorder (aOR 6.83; 95% CI 4.06–11.48). Of the narcoleptic patients that were comorbid with depression, >50% had been diagnosed with depression prior to being diagnosed with narcolepsy.

Conclusions

This nationwide data study revealed that narcolepsy and depression commonly co-occurred. Since some symptoms of narcolepsy overlapped with those of depressive disorders, the findings serve as a reminder that clinicians must pay attention to the comorbidity of narcolepsy and depression.

Introduction

Narcolepsy is a lifelong disabling sleep disorder that is characterized by excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, fragmented nocturnal sleep, and hypnagogic hallucination [1]. Patients suffering from narcolepsy complain of excessive daytime sleepiness nearly every day, which may develop into irresistible sleep episodes. Cataplexy, another core symptom of narcolepsy, is characterized by the sudden loss of muscle tone, which is often prompted by intense emotion or excitement. The lifelong prevalence of narcolepsy is approximate 1 in 2000 in the general population, and this condition can severely hinder daily activities [2], [3]. Furthermore, the high probability of having a comorbid condition, such as obesity, epilepsy, other sleep disorder, anxiety, and depression, significantly impacts a narcoleptic patient's daily function, and may result in delayed diagnosis and improper treatment [1], [4].

Depression is a common but serious mood disorder; symptoms affect an individual's feelings, thoughts, drive, and ability to handle daily activities and functions [5]. Therefore, identifying depression among narcoleptic patients is vital for providing adequate intervention. Vignatelli et al. found that the presence of depressive symptoms was the major independent predictor of health-related quality of life over a 5-year period in narcoleptic individuals [6]. An increased risk of suicide ideation may also be associated with excessive daytime sleepiness, particularly when comorbid with a depressive disorder [7]. However, many studies have reported a high ratio of depressive moods among narcoleptic patients, although the incidence of depressive disorders related to narcoleptic patients remains unsettled. Ruoff et al. found that narcolepsy is associated with a wide range of mental illnesses, particularly anxiety and depressive disorders [8]. Furthermore, Ohayon et al. suggested that mood and anxiety disorders occurred more frequently among the narcoleptic group than the control group in their study, with major depressive disorder and social anxiety disorder being the most common [9]. Previous studies using self-reported questionnaires, such as Medical Outcome Short Form-36 (SF-36) and Beck Depression Inventory (BDI), have revealed that 45.1–56.9% of narcoleptic patients suffer from depression [10], [11]. In contrast, two case–control studies that employed a structured psychiatric interview indicated that the prevalence of depressive disorders among narcoleptic patients was not higher than that of the healthy comparison group [12], [13]. For example, Vourdas et al. found that 16% of narcoleptic patients and 18% of the control group had one or more episodes that met the DSM-IV criteria for major depression [12]. Likewise, Fortuyn et al. reported that 7% of narcoleptic patients had a current major depressive episode with 3% of controls [13]. Therefore, it remains controversial as to whether narcolepsy patients have a higher rate of depression.

One possible reason for the discrepancy in the comorbid rate of narcolepsy and depression is the difficulty of differential diagnosis. Many somatic symptoms of narcoleptic patients (eg, sleep disturbance, fatigue, decreased attention, and weight changes) can also be considered to be depressive symptoms [14], thus posing a diagnostic dilemma when attempting to differentiate these overlapping symptoms between narcolepsy and depressive disorders in clinical settings. As a result, investigating the time sequence of the diagnoses of narcolepsy and depression may help to clarify the complexity among narcoleptic patients comorbid with a depressive disorder. It is assumed that some narcoleptic patients are diagnosed with depression prior to their narcolepsy diagnosis, while depression may be identified later in others.

Therefore, this nationwide population-based analysis was conducted to clarify the co-occurrence rate of narcolepsy and depressive disorders. An epidemiological methodology was also used to examine the time sequence between narcolepsy and depressive disorder diagnoses.

Section snippets

Data source

The Institutional Review Board at Chang Gung Memorial Hospital approved this study. Data for this study were obtained from the ambulatory claims database of the National Health Insurance Research Database of Taiwan (NHIRD-TW). Implemented in 1995, National Health Insurance (NHI) is the compulsory universal health insurance program in Taiwan. As of the end of 2000, 22.3 million people in Taiwan (>96% of the population) were enrolled in the NHI program. The study used two subsets of the NHIRD-TW,

Results

Table 1 shows the characteristics of the narcolepsy group and the control group. Compared to the control group, the narcolepsy group was more likely to have comorbidities of ADHD (8.8%), obesity (3.1%), epilepsy (8.9%), and intellectual disability (2.3%). During the monitoring period, 32.7%, 24.8%, and 10.9% of the narcoleptic patients were comorbid with any depressive, dysthymic, and major depressive disorder, respectively. In contrast, 6.3%, 4.4%, and 1.6% of the control subjects had any

Discussion

This study used a nationwide population database to demonstrate the comorbidity of narcolepsy and depression, and observed the time sequence between narcolepsy and depressive disorder diagnoses. When compared to the non-narcoleptic group, patients with narcolepsy had more than a six-fold greater risk of comorbidity with a depressive disorder, dysthymic disorder, or major depressive disorder. In line with this finding, some previous studies have also supported the high co-occurrence rate of

Acknowledgments

This study was sponsored by the Chang Gung Memorial Hospital Research Projects (CMRPG8D0581, CMRPG2G0071, CLRPG2C0023 and CGRPG2F0021). This study was based in part on data from the NHIRD-TW provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by the National Health Research Institutes (registration number: NHIRD-102-088). The interpretations and conclusions contained herein do not represent those of the National Health Insurance Administration,

References (36)

  • F.M. Schmidt et al.

    CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls

    Psychiatry Res

    (2011)
  • M.C. Meinzer et al.

    The co-occurrence of attention-deficit/hyperactivity disorder and unipolar depression in children and adolescents: a meta-analytic review

    Clin Psychol Rev

    (2014)
  • M.J. Lee et al.

    Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: a nationwide population-based study in Taiwan

    J Affect Disord

    (2016)
  • E. Morrish et al.

    Factors associated with a delay in the diagnosis of narcolepsy

    Sleep Med

    (2004)
  • C.M. Tseng et al.

    Adult narcoleptic patients have increased risk of cancer: a nationwide population-based study

    Cancer Epidemiol

    (2015)
  • F.L. Rocca et al.

    Narcolepsy during childhood: an update

    Neuropediatrics

    (2015)
  • S. Overeem et al.

    Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives

    J Clin Neurophysiol

    (2001)
  • M. Goswami

    The influence of clinical symptoms on quality of life in patients with narcolepsy

    Neurology

    (1998)
  • Cited by (29)

    • 2018 worldwide survey of health-care providers caring for patients with narcolepsy: WSS narcolepsy task force

      2021, Sleep Medicine
      Citation Excerpt :

      The wider use of the MWT among providers in Europe & Oceania is notable; in particular when considering that people in the USA drive the most when compared to the rest of the world. Consistent with previous reports [11], there was a high comorbidity of depression among patients cared by participating health-care providers. The complexity of the relationship between symptoms of EDS, psychiatric and sleep disorders has been well documented [12,13] but remains poorly understood.

    • Pleasure, addiction, and hypocretin (orexin)

      2021, Handbook of Clinical Neurology
    View all citing articles on Scopus
    View full text